Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

LightLab Imaging Begins Human Studies of OCT for Optical Biopsy

Facebook Twitter LinkedIn Email Comments
WESTFORD, Mass., Oct. 19 -- LightLab Imaging L.L.C. began a first round of human studies of its optical biopsy forceps and the latest generation of its optical coherence tomography (OCT) ultra high-resolution imaging platform. The study, being conducted at Duke University, is focused on detecting precancerous tissues in patients diagnosed with "Barrett's esophagus," and directing the associated tissue biopsies.

Barrett's esophagus is a condition associated with gastroesophageal reflux disease, when the normal tissue of the esophagus is replaced over time by tissues more similar to those lining the stomach or small intestine. Barrett's esophagus is easily seen by endoscopy, but a diagnosis of cancer and tissue changes that are precursors of cancer can at present be made only through biopsies and subsequent histological review under a microscope. Under the current biopsy protocol, four samples of the Barrett's segment of the esophagus are taken at random every 2 centimeters. The LightLab OCT platform uses advanced photonics and signal processing techniques to allow microscopic imaging inside the body. The LightLab optical biopsy forceps uses a single fiber optic strand .006" in diameter to obtain images of the Barrett's segment at resolutions much higher than any conventional imaging technology.
Oct 2001
MicroscopyNews & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.